Electrophysiological Effects of Clentiazem, a New Ca2+ Antagonist, on Rabbit Hearts

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 5, 1996, Pages 615-621

  Miyazaki, Kiyoshi ^a,b   Adaniya, Hitoshi ^a   Sawanobori, Tohru ^a   Hiraoka, Masayasu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Atrioventricular node Sinoatrial node; Ca2+ antagonist; Clentiazem; Electrophysiology; Langendorff perfused heart

Indexed keywords

BENZOTHIAZEPINE DERIVATIVE; CALCIUM ANTAGONIST; CLENTIAZEM; DILTIAZEM;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM CONDUCTION; HEART CONDUCTION; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART REPOLARIZATION; HEART VENTRICLE CONDUCTION; HIS BUNDLE; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; HEART CONDUCTION SYSTEM; RABBITS;

EID: 0029863711     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199605000-00001     Document Type: Article

References (24)

1. Narita H, Murata S, Yabana H, et al. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs. Arzneimittelforschung 1988;38:515-20.
2. Murata S, Kikkawa K, Yabana H, Nagao T. Cardiovascular effects of a new 1,5-benzothiazepine calcium antagonist in anesthetized dogs. Arzneimittelforschung 1988;38:521-5.
3. Kikkawa K, Murata S, Nagao T. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries. Arzneimittelforschung 1988;38: 526-31.
4. Nishiye E, Nakao K, Kitamura K, Kuriyama H. Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery. J Pharmacol Exp Ther 1989;250:1079-86.
5. Xiong Z, Sakaki T, Inoue Y, Kitamura K, Kuriyama H. Inhibitory actions of diltiazem and its derivative, TA3090 on the Ba-current recorded from smooth muscle cells of the rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol 1990;341:373-80.
6. Narita H, Ginsburg R. In-vitro study of the effect of clentiazem on rabbit aorta and on myocardium. Cardiovasc Drugs Ther 1990;4: 723-30.
7. Narita H, Zera PH, Ginsburg R. Mechanism of action of clentiazem on human coronary artery and myocardium. Cardiovasc Drugs Ther 1990;4:1097-104.
8. Rubanyi G, Iqbal A, Schwartz A, Vanhoutte PM. Vascular action of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries. J Pharmacol Exp Ther 1991;259:639-42.
9. Fleckenstein A. Calcium antagonism in heart and smooth muscle - experimental facts and therapeutic prospects [Monograph]. New York: John Wiley, 1983.
10. Narimatsu A, Taira N. Effects on atrio-ventricular conduction of calcium-antagonistic coronary vasodilators, local anaesthetics and quinidine injected into the posterior and the anterior septal artery of the atrio-ventricular node preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol 1976;294:169-77.
11. Kawai C, Konishi T, Matsuyama E, Okazaki H. Effects of diltiazem on sinoatrial and atrioventricular nodes in comparison with other calcium-antagonist. In: Bing RJ, ed. New drug therapy with a calcium antagonist, diltiazem, Hakone Symposium '78. Amsterdam: Excerpta Medica, 1979:141.
12. Kawai C, Konishi T, Mastsuyama E, Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies. Circulation 1981;63:1035-42.
13. Eduard R, Williams JM, Hartmut G, Dennis MK. The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia. Circ Res 1983:52(suppl 1):163-8.
14. Satoh H, Tsuchida K. Comparison of a calcium antagonist, CD-349, with nifedipine, diltiazem, and verapamil in rabbit spontaneously beating sinoatrial node cells. J Cardiovasc Pharmacol 1993; 21:685-92.
15. Noma A, Morad M, Irisawa H. Does the "pacemaker current" generate the diastolic depolarization in the rabbit SA node cells? Pflugers Arch 1983;397:190-4.
16. Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev 1986;38:321-416.
17. Betriu A, Chaitman BR, Bourassa MG, et al. Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias. Circulation 1983;67:88-94.
18. Yeh SJ, Kou HC, Lin FC, Hung JS, Wu D. Effects of oral diltiazem in paroxysmal supraventricular tachycardia. Am J Cardiol 1983; 52:271-8.
19. Huycke EC, Sung RJ, Dias VC, et al., for the Multicenter Diltiazem PSVT Study Group. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study. J Am Coll Cardiol 1989; 13:538-44.
20. Schamroth L, Krikler DM, Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J 1972;1:660-2.
21. Sung RJ, Elser B, McAllister RG Jr. Intravenous verapamil for termination of re-entrant supraventricular tachycardias. Ann Intern Med 1980;93:682-9.
22. Rinkenberger RL, Prystowsky EN, Heger JJ, Troup PJ, Jackman WM, Zipes DP. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation 1980;62:996-1010.
23. Waxman HL, Myerburg RJ, Appel R, Sung RJ. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. Ann Intern Med 1981;94: 1-6.
24. Miyagawa K, Dohi Y, Ogihara M, Sato K. Administration of intravenous calcium before verapamil to prevent hypotension in elderly patients with paroxysmal supraventricular tachycardia. J Cardiovasc Pharmacol 1993;22:273-9.